TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/07/2025
Back to search
Official data from USPTO
BONRAYBIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
05/14/2025
Trademark type
Combined
Nice classes
10
Filing date
05/12/2016
Registration date
10/24/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/22/2023
Last transaction
05/14/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/01/2016
First use in commerce
02/01/2017
Drawing code
5
Owner type
03
Owner location
Taichung City, TW
Examiner
ORTIGA PALMER, RAMONA
Law office
M80
Current location
TMO LAW OFFICE 117
Mark description
The mark consists of the word "bonraybio" in stylized font, lower case letters.
Holders and representatives
Holders
BONRAYBIO CO., LTD.
Representatives
Paul Cosmovici
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Medical and surgical catheters; medical apparatus and instrument for diagnostic useapparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testingcytology and cell-based testing; medical apparatus and instruments for monitoring oxymetorygas analysis and vital signs; medical apparatus and units for dosagemeasuring and monitoringdrug delivery devices and systems; medical devices and apparatusultrasound imaging apparatusscanners and needle guidesparts and fittings therefor ; medical apparatus and instruments for use in endovascularcardiovascularendoscopy procedures; medical instruments for measuring and displaying blood pressurelung capacity; immunochemical testing apparatus for medical use; apparatus used in implementing diagnosis tests designed to detect the abnormal prion protein
Publications
History of USPTO decisions and trademark events.
29 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/07/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/07/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/22/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/22/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/22/2023
E815
TEAS SECTION 8 & 15 RECEIVED
05/25/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/24/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
10/24/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/20/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/19/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/29/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/28/2017
IUAF
USE AMENDMENT FILED
08/08/2017
EISU
TEAS STATEMENT OF USE RECEIVED
08/08/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/27/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/02/2017
PUBO
PUBLISHED FOR OPPOSITION
05/02/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/12/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/18/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/04/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/03/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/03/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/07/2016
GNRT
NON-FINAL ACTION E-MAILED
09/07/2016
CNRT
NON-FINAL ACTION WRITTEN
09/07/2016
DOCK
ASSIGNED TO EXAMINER
08/27/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/18/2016
NWAP
NEW APPLICATION ENTERED
05/16/2016
Continuous trademark protection
Get notified about every new filing that threatens BONRAYBIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.